Spots Global Cancer Trial Database for stage ii renal cell cancer
Every month we try and update this database with for stage ii renal cell cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Kidney-Sparing Surgery Compared With Kidney Removal in Treating Patients With Kidney Cancer | NCT00002473 | Kidney Cancer | conventional su... | - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers | NCT01846520 | Healthy Subject Localized Trans... Metastatic Tran... Psychosocial Ef... Recurrent Bladd... Recurrent Cervi... Recurrent Colon... Recurrent Gastr... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Recurrent Renal... Recurrent Trans... Recurrent Ureth... Recurrent Uteri... Regional Transi... Stage II Bladde... Stage II Renal ... Stage II Urethr... Stage IIA Cervi... Stage IIA Colon... Stage IIA Gastr... Stage IIA Ovari... Stage IIA Ovari... Stage IIA Pancr... Stage IIA Recta... Stage IIA Uteri... Stage IIB Cervi... Stage IIB Colon... Stage IIB Gastr... Stage IIB Ovari... Stage IIB Ovari... Stage IIB Pancr... Stage IIB Recta... Stage IIB Uteri... Stage IIC Colon... Stage IIC Ovari... Stage IIC Ovari... Stage IIC Recta... Stage III Bladd... Stage III Pancr... Stage III Renal... Stage III Ureth... Stage IIIA Cerv... Stage IIIA Colo... Stage IIIA Gast... Stage IIIA Ovar... Stage IIIA Ovar... Stage IIIA Rect... Stage IIIA Uter... Stage IIIB Cerv... Stage IIIB Colo... Stage IIIB Gast... Stage IIIB Ovar... Stage IIIB Ovar... Stage IIIB Rect... Stage IIIB Uter... Stage IIIC Colo... Stage IIIC Gast... Stage IIIC Ovar... Stage IIIC Ovar... Stage IIIC Rect... Stage IIIC Uter... Stage IV Bladde... Stage IV Gastri... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Renal ... Stage IV Urethr... Stage IVA Cervi... Stage IVA Colon... Stage IVA Recta... Stage IVA Uteri... Stage IVB Cervi... Stage IVB Colon... Stage IVB Recta... Stage IVB Uteri... Ureter Cancer Stage IIA Lung ... Stage IIB Lung ... Stage IIIA Lung... Stage IIIB Lung... | educational int... telephone-based... quality-of-life... questionnaire a... | 18 Years - | City of Hope Medical Center | |
| Gene Expression in Normal Tissue and Tumor Tissue From Patients Who Have Undergone Surgery For Kidney Cancer | NCT00899860 | Kidney Cancer | - 120 Years | Wake Forest University Health Sciences | ||
| Monoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney Cancer | NCT00087022 | Kidney Cancer | girentuximab placebo | 18 Years - 120 Years | Heidelberg Pharma AG | |
| Monoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney Cancer | NCT00087022 | Kidney Cancer | girentuximab placebo | 18 Years - 120 Years | Heidelberg Pharma AG | |
| Vaccine Therapy in Treating Patients With Kidney Cancer | NCT00096629 | Kidney Cancer | human prostate-... mouse prostate-... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer | NCT00727532 | Hereditary Clea... Kidney Cancer | Sorafenib | 18 Years - 120 Years | Northwestern University | |
| DNA Analysis of Blood and/or Tissue Samples From Patients With Primary Kidney Cancer Receiving Sorafenib on Clinical Trial MRC-RE05-SORCE | NCT00900536 | Kidney Cancer | mutation analys... polymorphism an... protein express... immunohistochem... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Sunitinib Malate and Bevacizumab in Treating Patients With Kidney Cancer or Advanced Solid Malignancies | NCT01243359 | Clear Cell Rena... Recurrent Renal... Stage I Renal C... Stage II Renal ... Stage III Renal... Stage IV Renal ... Unspecified Adu... | sunitinib malat... bevacizumab pharmacological... laboratory biom... fluorine F 18 f... positron emissi... computed tomogr... | 18 Years - | National Cancer Institute (NCI) | |
| Sunitinib and Surgery in Treating Patients With Localized or Metastatic Kidney Cancer | NCT00849186 | Kidney Cancer | sunitinib malat... neoadjuvant the... therapeutic con... | 18 Years - | Roswell Park Cancer Institute | |
| Stereotactic Radiation Therapy in Treating Patients With Kidney Tumors | NCT00445757 | Kidney Cancer | conventional su... stereotactic ra... | 18 Years - | Case Comprehensive Cancer Center | |
| Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer | NCT00436410 | Adrenocortical ... Breast Cancer Colorectal Canc... Gastrointestina... Kidney Cancer Liver Cancer Melanoma (Skin) Ovarian Cancer Pancreatic Canc... Sarcoma | colloidal gold-... electron micros... pharmacological... conventional su... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| DNA Analysis of Blood and/or Tissue Samples From Patients With Primary Kidney Cancer Receiving Sorafenib on Clinical Trial MRC-RE05-SORCE | NCT00900536 | Kidney Cancer | mutation analys... polymorphism an... protein express... immunohistochem... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Vaccine Therapy in Treating Patients With Kidney Cancer | NCT00096629 | Kidney Cancer | human prostate-... mouse prostate-... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer | NCT02664883 | Healthy Subject Metastatic Rena... Recurrent Renal... Stage I Renal C... Stage II Renal ... Stage III Renal... | Computed Tomogr... Cytology Specim... Laboratory Biom... Magnetic Resona... | 25 Years - | University of Southern California | |
| Interstitial Brachytherapy for the Treatment of Unresectable/Unablatable Kidney Cancer | NCT04473781 | Stage I Renal C... Stage II Renal ... | Interstitial Ra... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Sunitinib and Surgery in Treating Patients With Localized or Metastatic Kidney Cancer | NCT00849186 | Kidney Cancer | sunitinib malat... neoadjuvant the... therapeutic con... | 18 Years - | Roswell Park Cancer Institute | |
| Sorafenib in Treating Patients Undergoing Surgery for Stage II, Stage III, or Stage IV Kidney Cancer | NCT00405366 | Kidney Cancer | sorafenib tosyl... | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| sEphB4-HSA Before Surgery in Treating Patients With Bladder Cancer, Prostate Cancer, or Kidney Cancer | NCT02767921 | Infiltrating Bl... Recurrent Bladd... Stage I Prostat... Stage I Renal C... Stage II Bladde... Stage II Renal ... Stage IIA Prost... Stage IIB Prost... Stage III Prost... Stage III Renal... | Cytology Specim... Laboratory Biom... Radical Cystect... Recombinant Eph... Therapeutic Con... | 18 Years - | University of Southern California | |
| Bryostatin 1 In Treating Patients With Progressive Kidney Cancer | NCT00005056 | Kidney Cancer | bryostatin 1 | 18 Years - | National Cancer Institute (NCI) | |
| Fluorescence Imaging in Finding Tumors in Patients With Kidney Tumors | NCT01281488 | Recurrent Renal... Stage I Renal C... Stage II Renal ... | fluorescence im... laparoscopic su... indocyanine gre... | 18 Years - | City of Hope Medical Center | |
| S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery | NCT01120249 | Kidney Cancer | everolimus placebo | 18 Years - 120 Years | SWOG Cancer Research Network | |
| Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants | NCT00900276 | Bladder Cancer Kidney Cancer Transitional Ce... Urethral Cancer | immunologic tec... laboratory biom... mass spectromet... | 18 Years - 120 Years | Wake Forest University Health Sciences | |
| Biomed 101 and Interleukin-2 in Treating Patients With Kidney Cancer | NCT00004890 | Drug Extravasat... Kidney Cancer | aldesleukin Biomed 101 | 18 Years - | National Cancer Institute (NCI) | |
| Stereotactic Radiation Therapy in Treating Patients With Kidney Tumors | NCT00445757 | Kidney Cancer | conventional su... stereotactic ra... | 18 Years - | Case Comprehensive Cancer Center | |
| Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial | NCT06432036 | Stage I Renal C... Stage II Renal ... | Angiogram Biospecimen Col... Computed Tomogr... Radioembolizati... Single Photon E... Survey Administ... Yttrium Y 90 Gl... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Biomed 101 and Interleukin-2 in Treating Patients With Kidney Cancer | NCT00004890 | Drug Extravasat... Kidney Cancer | aldesleukin Biomed 101 | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors | NCT00335556 | Childhood Renal... Clear Cell Rena... Clear Cell Sarc... Papillary Renal... Rhabdoid Tumor ... Stage I Renal C... Stage I Renal W... Stage II Renal ... Stage II Renal ... Stage III Renal... Stage III Renal... Stage IV Renal ... Stage IV Renal ... | Doxorubicin Hyd... Irinotecan Hydr... Conventional Su... Cyclophosphamid... Etoposide Carboplatin Dactinomycin Vincristine Sul... Radiation Thera... Laboratory Biom... | - 29 Years | Children's Oncology Group | |
| S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery | NCT01120249 | Kidney Cancer | everolimus placebo | 18 Years - 120 Years | SWOG Cancer Research Network | |
| Radiosurgery in Treating Patients With Kidney Tumors | NCT00458484 | Kidney Cancer | stereotactic ra... Renal Biopsy Serum Blood Mar... | 18 Years - | Case Comprehensive Cancer Center | |
| Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial | NCT06432036 | Stage I Renal C... Stage II Renal ... | Angiogram Biospecimen Col... Computed Tomogr... Radioembolizati... Single Photon E... Survey Administ... Yttrium Y 90 Gl... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Tivozanib Before Surgery in Treating Patients With Localized Kidney Cancer | NCT01769885 | Stage II Renal ... Stage III Renal... | tivozanib therapeutic con... | 18 Years - | Roswell Park Cancer Institute | |
| Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer | NCT02664883 | Healthy Subject Metastatic Rena... Recurrent Renal... Stage I Renal C... Stage II Renal ... Stage III Renal... | Computed Tomogr... Cytology Specim... Laboratory Biom... Magnetic Resona... | 25 Years - | University of Southern California | |
| Perfusion Magnetic Resonance Imaging in Diagnosing Patients With Kidney Tumors | NCT02526511 | Stage I Renal C... Stage II Renal ... Stage III Renal... Stage IV Renal ... | Arterial Spin L... Dynamic Contras... Dynamic Suscept... Perfusion Magne... | 18 Years - | Rutgers, The State University of New Jersey | |
| Perfusion Magnetic Resonance Imaging in Diagnosing Patients With Kidney Tumors | NCT02526511 | Stage I Renal C... Stage II Renal ... Stage III Renal... Stage IV Renal ... | Arterial Spin L... Dynamic Contras... Dynamic Suscept... Perfusion Magne... | 18 Years - | Rutgers, The State University of New Jersey | |
| Sorafenib in Treating Patients at Risk of Relapse After Undergoing Surgery to Remove Kidney Cancer | NCT00492258 | Kidney Cancer | sorafenib tosyl... adjuvant therap... | 18 Years - | National Cancer Institute (NCI) | |
| Interstitial Brachytherapy for the Treatment of Unresectable/Unablatable Kidney Cancer | NCT04473781 | Stage I Renal C... Stage II Renal ... | Interstitial Ra... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Pazopanib Hydrochloride Before Surgery in Treating Patients With Kidney Cancer | NCT01158521 | Clear Cell Rena... Stage I Renal C... Stage II Renal ... Stage III Renal... | pazopanib hydro... therapeutic con... | 18 Years - | Case Comprehensive Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
